These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 30932883)
1. Relationship between p-cofilin and cisplatin resistance in patients with ovarian cancer and the role of p-cofilin in prognosis. Qin Y; Li W; Long Y; Zhan Z Cancer Biomark; 2019; 24(4):469-475. PubMed ID: 30932883 [TBL] [Abstract][Full Text] [Related]
2. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model. Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326 [TBL] [Abstract][Full Text] [Related]
3. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines. Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764 [TBL] [Abstract][Full Text] [Related]
4. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression. Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490 [TBL] [Abstract][Full Text] [Related]
5. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines]. Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691 [TBL] [Abstract][Full Text] [Related]
6. [Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines]. Li NW; Wang HJ; Yang LY; Jia XB; Chen C; Wang X Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):865-70. PubMed ID: 24490491 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496 [TBL] [Abstract][Full Text] [Related]
8. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP]. Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863 [TBL] [Abstract][Full Text] [Related]
9. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis. Zhou Y; Liu T; Wu Q; Wang H; Sun Y Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234 [TBL] [Abstract][Full Text] [Related]
10. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines]. Yang X; Zheng F; Xing H; Gao Q; Wang W; Lu Y; Wang S; Ma D Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):544-7. PubMed ID: 12667321 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells. Dai C; Xu P; Liu S; Xu S; Xu J; Fu Z; Cao J; Lv M; Zhou J; Liu G; Zhang H; Jia X Arch Gynecol Obstet; 2021 May; 303(5):1271-1281. PubMed ID: 33151424 [TBL] [Abstract][Full Text] [Related]
13. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084 [TBL] [Abstract][Full Text] [Related]
14. MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. Ren L; Xiao L; Hu J J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):721-4. PubMed ID: 18231753 [TBL] [Abstract][Full Text] [Related]
15. [Expression of miR-130a in cisplatin resistant cell lines of ovarian cancer]. Yang LY; Wang HJ; Jia XB; Wang X; Luo J; Zhang XY Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):60-4. PubMed ID: 22455133 [TBL] [Abstract][Full Text] [Related]
16. MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells. Rao YM; Shi HR; Ji M; Chen CH J Huazhong Univ Sci Technolog Med Sci; 2013 Aug; 33(4):567-572. PubMed ID: 23904379 [TBL] [Abstract][Full Text] [Related]
17. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398 [TBL] [Abstract][Full Text] [Related]
18. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells. Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139 [TBL] [Abstract][Full Text] [Related]
19. PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process. Hou L; Hou X; Wang L; Li Z; Xin B; Chen J; Gao X; Mu H Cancer Biomark; 2017 Dec; 21(1):187-194. PubMed ID: 29103028 [TBL] [Abstract][Full Text] [Related]
20. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro]. He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]